The Business Model of Isomorphic Labs
As of August 26, 2026
Isomorphic Labs is a London-headquartered AI-first drug discovery company founded in 2021 and led by founder and CEO Sir Demis Hassabis. The operating company is Isomorphic Labs Limited, a company incorporated in England and Wales.
The company develops predictive and generative artificial-intelligence models for drug design, building on and beyond AlphaFold technology. Its AI drug design engine is used across therapeutic areas and drug modalities, alongside partnered and internal drug-discovery programs.
Hard Facts
Business Model Canvas
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeBusiness Model Patterns
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free
SWOT Analysis
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeWhat makes Isomorphic Labs special?
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeMarketing Insights
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free